Targeting neuronal activity-regulated neuroligin-3 dependency for high-grade glioma therapy
Humsa S. Venkatesh, Lydia T. Tam, Pamelyn J. Woo, James Lennon, Surya Nagaraja, Shawn M. Gillespie, Jing Ni, Damien Y. Duveau, Patrick J. Morris, Jean J. Zhao, Craig J. Thomas, Michelle Monje
This study shows that targeting Nlgn3 secretion via ADAM10 inhibitors can block high-grade glioma growth in mouse models.
Nature · Sep 1, 2017Peer-reviewedNeuroscience